MIRA Pharmaceuticals, Inc.MIRANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-37.18%
↓ 402% vs avg
Percentile
P13
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-7.41%
Historical baseline
PeriodValue
Q3 2025-37.18%
Q2 202550.94%
Q1 20259.70%
Q4 20242.01%
Q3 2024-113.22%
Q2 202417.68%
Q1 202450.84%
Q4 2023-21.23%
Q3 2023-166.53%
Q2 202338.55%
Q1 2023-10.24%
Q4 202225.82%
Q3 2022-3.40%
Q2 202237.74%
Q1 20220.00%
Q1 20210.00%